17-year-old Dubai student builds CareCheck AI for breast cancer awareness

Dubai student Saiyette Aima, 17, has built CareCheck, an AI breast-health information platform, after losing her grandmother to breast cancer in 2020, according to The Times of India.

The story matters for UAE clinic operators, insurers and patients because breast cancer screening is a high-volume, protocol-driven service where delayed presentation, unclear eligibility and weak follow-up all carry cost. In Dubai, the relevant regulator is the Dubai Health Authority (DHA). In Abu Dhabi and Al Ain it is the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, the federal reference point is the Ministry of Health and Prevention (MOHAP).

What CareCheck is trying to solve

Aima told Khaleej Times that her grandmother was diagnosed with Stage 3 breast cancer after noticing a small mark on her neck. She was 10 when the illness entered her family life. The Times of India reported on 8 September 2026 that Aima later developed CareCheck and extended her awareness work to India.

"I watched her go through chemotherapy and radiation." Saiyette Aima, speaking to Khaleej Times

For UAE providers, the operational point is direct. A patient education tool can increase screening demand, but it cannot replace clinical assessment, diagnostic imaging or physician review. Any AI interface used in a Dubai clinic should route symptomatic patients to a licensed clinician, identify emergency red flags and keep a record of the advice shown to the patient.

That matters because breast screening is split into at least two different workflows:

• Screening mammography for women without symptoms, commonly referenced for women aged 40 and above in UAE provider and payer guidance.
• Diagnostic mammography for a lump, nipple change, skin change, pain or an abnormal clinical exam.
• Ultrasound or biopsy when imaging or clinical findings require follow-up.
• Oncology referral after confirmed malignancy or high suspicion.

What UAE clinics and insurers should check

The price signal is visible to patients. Advertised self-pay mammogram offers in Dubai commonly start around AED 199 to AED 300. Broader packages that add consultation, ultrasound or specialist review often sit between AED 500 and AED 1,100. Operators should verify their live tariff against their own billing system, because seasonal October campaigns and insurer networks change the patient bill.

For payers, the issue is eligibility and avoidable utilisation. Daman publishes mammography medical-policy material that refers to annual screening mammograms for females over 40 years. In Abu Dhabi, Thiqa members can access breast cancer screening through the IFHAS comprehensive screening programme, according to Abu Dhabi Public Health Centre materials. Dubai clinics dealing with Sukoon members should check the member plan, network status and pre-authorisation rule before booking imaging.

CIOs should read CareCheck as a procurement warning. A breast-health chatbot or risk screener needs a dated medical content library, audit logs, consent capture and a referral handoff into the clinic's EMR or CRM. If it collects symptoms, family history or imaging history, it is handling health data. That brings privacy, hosting and access-control questions before marketing teams put the tool on WhatsApp, Instagram or a clinic website.

The UAE opportunity is in follow-up

Aima's work sits in a larger gap: awareness campaigns can create intent, but clinics often lose patients between inquiry, booking, imaging, results and specialist referral. For COOs, the practical test is whether a breast-health campaign produces completed mammograms and documented follow-up within a defined timeframe, such as seven to 14 days after an abnormal result.

Medical directors should require written escalation rules. A patient reporting a palpable lump should not be treated as a routine screening lead. A patient aged under 40 may still need clinical examination, ultrasound or specialist review depending on symptoms and family history. AI copy should avoid diagnostic certainty and should tell patients when to seek same-week clinical care.

The next step for UAE operators is simple. Map the full breast pathway by emirate, payer and facility licence: DHA for Dubai, DOH for Abu Dhabi and Al Ain, and MOHAP for the northern emirates. Then test whether every digital entry point sends the patient to the correct licensed service. Patients looking for licensed oncology providers can start with the UAE Open Healthcare Directory.